The United States Court of Appeals for the First Circuit recently joined the Sixth Circuit (2023) and Eighth Circuit (2022) ...
Hosted on MSN5mon
Regeneron falls after judge denies injunction blocking Amgen Eylea biosimilar (update)Regeneron Pharmaceuticals (NASDAQ:REGN) dropped 4.5% after a judge denied the company's motion for a preliminary injunction to block an Amgen biosimilar version of Regeneron's blockbuster Eylea drug.
It has been about a month since the last earnings report for Regeneron (REGN). Shares have lost about 4.1% in that time frame, underperforming the S&P 500. Will the recent negative trend continue ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback